47.50p-1.50 (-3.06%)11 Jun 2021, 17:21
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Optibiotix Health PLC Fundamentals

Company NameOptibiotix Health PLCLast Updated2021-06-11
Shares in Issue87.941 mMarket Cap£41.77 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.02EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.1022Debt Equity Ratio0.1344
Asset Equity Ratio1.3062Cash Equity Ratio0.2619
Quick Ratio4.4390Current Ratio5.25
Price To Book Value7.4963ROCE0

Optibiotix Health PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Optibiotix Health PLC Company Financials

Tangible Assets£393.00£3,143.00
Intangible Assets£2.63 m£2.25 m
Investments£3.09 m£3.74 m
Total Fixed Assets£5.73 m£6.00 m
Cash & Equivalents£455,608.00£1.32 m
Other Assets00
Total Assets£7.04 m£8.03 m
Creditors within 1 year£561,623.00£520,989.00
Creditors after 1 year£1.25 m£446,161.00
Other Liabilities00
Total Liabilities£1.81 m£967,150.00
Net assets£5.23 m£7.06 m
Called up share capital£1.71 m£1.69 m
Share Premium£1.65 m£1.60 m
Profit / Loss-£2.24 m-£1.95 m
Other Equity£5.20 m£7.03 m
Preference & Minorities£35,782.00£36,897.00
Total Capital Employed£5.23 m£7.06 m
Debt Ratio00
Assets / Equity1.30621.3062
Cash / Equity0.26190.2619
Cash Flow20192018
Cash from operating activities-£1.72 m-£1.23 m
Cashflow before financing-£273,776.00£547,469.00
Increase in Cash-£868,699.00£76,876.00
Cost of sales£352,080.00£162,782.00
Gross Profit£392,803.00£351,507.00
Operating Profit-£2.17 m-£1.50 m
Pre-Tax profit-£2.24 m-£1.95 m

Optibiotix Health PLC Company Background

ActivitiesOptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies on researching the area of biotechnology. Its activities include identification of microbial strains which can affect human metabolism and physiology, development of microbiome modulators, natural sugars and proteins. The company markets its products in the United Kingdom under trademark names such as OptiBiotix, SweetBiotix and SkinBiotix.
Latest Interim Date24 Sep 2020
Latest Fiscal Year End Date18 Jun 2021

Optibiotix Health PLC Directors

2020-06-11Mr. Richard Colin Neil Davidson CBENon-Executive Director,Chairman
2013-11-18Mr. Leslie Christopher BarberNon-Executive Director,chairman
2013-11-18Mr. Clive Richard Garston Non-Executive Director
2017-12-29Mr. Adam ReynoldsNon-Executive Director
2018-05-24Mr. David Eric EvansNon-Executive Director,Chairman
2013-02-05Mr. Norman Fetterman FCANon-Executive Director
2015-05-29Dr. Mark Andrew WyattNon-Executive Director
2014-08-05Mr. Nicholas Christian Paul Nelson Non-Executive Director
2021-04-16Mr. Stephen William Hammond MPNon-Executive Director
2013-11-18Mr. Alexander Stuart DowdeswellExecutive Director,Chief Executive Officer and Company Sec
2021-04-21Mr. Stephen Patrick O'HaraExecutive Director,Chief Executive Officer
2020-05-28Dr. Gareth Allan BarkerNon-Executive Director
2018-05-23Mr. Robert Jim LairdExecutive Director,Commercial Director
2020-05-28Mr. Per RehneExecutive Director,Commercial Director
2019-08-28Ms. Christina Mary Wood Executive Director,Sales and Marketing Director
2020-06-11Dr. Sofia KolydaExecutive Director,Research and Development
2020-06-11Mr. Michael Sean Christie Non-Executive Director
2020-06-11Mr. Frederic NarbelExecutive Director

Optibiotix Health PLC Contact Details

Company NameOptiBiotix Health PLC
AddressInnovation Centre, Innovation Way, Heslington, York, YO10 5DG
Telephone+44 1904435100

Optibiotix Health PLC Advisors

Solicitorturnerparkinson LLP
Phone+44 2072200500
Fax+44 2072200597
RegistrarShare Registrars Limited
Phone+44 1252821390
Fax+44 1252719232
AuditorJeffreys Henry LLP
Phone+44 2073092222
Fax+44 2073092309
Financial PR AdviserWalbrook PR
Phone+44 2079338780
Fax+44 2079338781
Financial AdviserFisher Corporate Plc
Phone020 7388 7000
Nominated AdviserCairn Financial Advisers LLP
Phone+44 2072130880